MRI changes associated with vigabatrin treatment mimicking tumor progression

Pediatric Blood and Cancer

Volumn 55, Issue 6, 2010, Pages 1221-1223

  Yang, Tong ^a   Pruthi, Sumit ^a   Geyer, J Russell ^a   Ojemann, Jeffrey G ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Anaplastic oligodendroglioma; DWI FLAIR; Vigabatrin

Indexed keywords

CORTICOTROPIN; ETIRACETAM; PHENOBARBITAL; TEMOZOLOMIDE; VIGABATRIN;

ANAPLASTIC OLIGODENDROGLIOMA; ARM; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CRANIOTOMY; DIFFUSION WEIGHTED IMAGING; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG WITHDRAWAL; FEMALE; FLUID ATTENUATED INVERSION RECOVERY; FOLLOW UP; GLOBUS PALLIDUS; HAND; HEMISPHERECTOMY; HUMAN; INFANT; INFANTILE SPASM; INTRACTABLE EPILEPSY; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE CARE; PRIORITY JOURNAL; REPEAT PROCEDURE; THALAMUS; TREATMENT DURATION;

ANTICONVULSANTS; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; INFANT; OLIGODENDROGLIOMA; SEIZURES; TREATMENT OUTCOME; VIGABATRIN;

EID: 77958531336     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.22626     Document Type: Article

References (12)

1. Appleton RE, Peters ACB, Mumford JP, et al. Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 1999; 40: 1627-1633.
2. Elterman RD, Shields WD, Mansfield KA, et al. Randomized trial of vigabatrin in patients with infantile spasms. Neurology 2001; 57: 1416-1421.
3. Peyster RG, Sussman NM, Hershey BL, et al. Use of ex vivo magnetic resonance imaging to detect onset of vigabatrin-induced intarmyelinic edema in canine brain. Epilepsia 1995; 36: 93-100.
4. Preece NE, Houseman J, King MD, et al. Development of vigabatrin-induced lesions in the rat brain studied by magnetic resonance imaging, histology and immunocytochemistry. Synapse 2004; 53: 36-43.
5. Desguerre I, Marti I, Valayannopoulos V, et al. Transient magnetic resonance diffusion abnormalities in West syndrome: The radiological expression of non-convulsive status epilepticus? Dev Med Child Neurol 2008; 50: 112-116.
6. Pearl PL, Vezina LG, Saneto RP, et al. Cerebral MRI abnormalities associated with vigabatrin therapy. Epilepsia 2009; 50: 184-194.
7. Wheless JW, Carmant L, Bebin M, et al. Magnetic resonance imaging abnormalities associated with vigabatrin in patients with epilepsy. Epilepsia 2009; 50: 195-205.
8. Razack N, Baumgartner J, Bruner J. Pediatric oligodendrogliomas. Pediatr Neurosurg 1998; 28: 121-129.
9. Kreiger PA, Okada Y, Simon S, et al. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Acta Neuropathol 2005; 109: 387-392.
10. Gilles FH, Sobel E, Leviton A, et al. Epidemiology of seizures in children with brain tumors. J Neuro-Oncol 1992; 12: 53-68.
11. Spencer DD, Spencer SS, Mattson RH, et al. Intracerebral masses in patients with intractable partial epilepsy. Neurology 1984; 34: 432-436.
12. Chenevert TL, Stegman LD, Taylor JMG, et al. Diffusion magnetic resonance imaging: An early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000; 92: 2029-2036.